HZNP - Horizon Therapeutics Q4 2021 Earnings Preview
Horizon Therapeutics (NASDAQ:HZNP) is scheduled to announce Q4 earnings results on Tuesday, Mar. 1, before market open. The consensus EPS estimate is $1.35 (+5.5% Y/Y) and the consensus revenue estimate is $995.9M (+33.6% Y/Y). Over the last 2 years, HZNP has beaten EPS estimates 88% of the time and has beaten revenue estimates 100% of the time. Over the last 3 months, EPS estimates have seen 0 upward revisions and 9 downward. Revenue estimates have seen 2 upward revisions and 1 downward. Last month, SA contributor Out of Ignorance wrote "Horizon Therapeutics: Powerful Pharma Player On Long-Term Growth Track", rating the stock Hold.
For further details see:
Horizon Therapeutics Q4 2021 Earnings Preview